Atraverse Medical Secures FDA Clearance for Revolutionary HOTWIRE RF Guidewire and Raises $12.5 Million in Seed Round Funding

San Diego-based medical device company Atraverse Medical has recently announced that its HOTWIRE radiofrequency (RF) guidewire has received FDA clearance. This innovative device allows for zero exchange left-heart access and serves as a rail for catheter-based therapy systems. Additionally, the company reported that its seed round funding was oversubscribed, totaling $12.5 million.

These accomplishments represent a significant advancement in commercializing Atraverse Medical’s top-tier left-heart access technology. The funding includes contributions from esteemed physicians, reputable venture investors, and successful medtech entrepreneurs. This financial support will enable the company to accelerate its research and development efforts as well as its early commercialization initiatives.

Atraverse Co-Founders Dr. Steven Mickelsen and Eric Sauter developed the HOTWIRE system, which introduces a new approach to left-heart access. Designed to be universally compatible with sheaths and featuring optimized RF technology, the HOTWIRE aims to enhance patient outcomes and streamline procedural workflows.

Dr. Mickelsen, a cardiac electrophysiology physician at Scripps Hospital in La Jolla, CA, expressed his dedication to medical innovation and improving the standard of care for procedures requiring transseptal access with the FDA clearance of the HOTWIRE. Dr. Devi Nair, Director of Cardiac Electrophysiology and Research at St. Bernard’s Medical Center, highlighted the potential of the HOTWIRE to revolutionize left-heart therapies, making procedures safer and more efficient. John Slump, CEO/President and Co-Founder of Atraverse Medical, remarked on the company’s rapid progress since its founding and how the completion of the seed round sets Atraverse Medical up for continued success in reshaping the field of left-heart access.

The HOTWIRE system is expected to have a significant impact on left-heart access technology by providing a new approach that is universally compatible with sheaths while featuring optimized RF technology that enhances patient outcomes and streamlines procedural workflows.

These accomplishments are a testament to Atraverse Medical’s commitment to innovation in healthcare technology